RIGEL PHARMACEUTICALS, INC. (RIGL) Gross profit 2018–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) annual gross profit history from SEC filings — each fiscal year as reported.
$274.7MFY2025 · since FY2018: $44.2M → $274.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $274.7M | +71.0% |
| FY2024 | $160.6M | +46.3% |
| FY2023 | $109.8M | -7.4% |
| FY2022 | $118.5M | -20.0% |
| FY2021 | $148.2M | +37.5% |
| FY2020 | $107.7M | +84.5% |
| FY2019 | $58.4M | +32.0% |
| FY2018 | $44.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice